Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid Dose Regimens in Cardiac Valve Surgery
NCT04911413Phase 4Completed
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Sep 2017
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial of tranexamic acid (3 arms), sponsored by Chinese Academy of Medical Sciences. Primary endpoint: Total postoperative drainage up to 7 days. Started Sep 2017; status: completed.
02
Drugs
tranexamic acid
Beyond the preview
Go deeper on NCT04911413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04911413.